Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.
Li, Dange; Hu, Yi; Werngren, Jim; Mansjö, Mikael; Zheng, Xubin; Drobniewski, Francis; Hoffner, Sven; Xu, Biao.
Antimicrob Agents Chemother
; 60(9): 5159-66, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27297481
Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993-2014.
Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009.
First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon.
Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance.
Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015-2017.
Line probe assay for detection of <i>Mycobacterium tuberculosis</i> complex: An experience from Central India.
Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
Molecular detection of mutations in isolates of multidrug resistant tuberculosis and tuberculosis suspects by multiplex allele specific PCR.
Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993-2008.
Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment.